Shares of Quest Diagnostics Inc. DGX rallied 2.27% to $175.56 Friday, on what proved to be an all-around great trading ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Quest Diagnostics (DGX – Research Report) yesterday and set a price ...

Citigroup cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a neutral rating in a report ...

Shares of Quest Diagnostics Inc. DGX slid 1.71% to $172.01 Wednesday, on what proved to be an all-around positive trading ...

A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...

Fintel reports that on March 4, 2025, Citigroup downgraded their outlook for Quest Diagnostics (NYSE:DGX) from Buy to Neutral ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Citi downgraded Quest Diagnostics (DGX) to Neutral from Buy with an unchanged price target of $185. The firm believes Quest is well positioned ...

We recently compiled a list of the Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In. In this article, we ...

In an age of capitation and value-based care, health plans must work harder than ever to offer tailored support to higher-risk members with chronic conditions.

Atria Wealth Solutions Inc. raised its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F ...

Quest Diagnostics will take over the kidney-focused lab testing portfolio of the dialysis giant Fresenius Medical Care—including services that Quest will then provide back to Fresenius as | The assets ...